Biota is a leading anti-infective drug development company based in MelbourneAustralia, with key expertise in respiratory diseases, particularly influenza. Biota developed the first-in-class neuraminidase inhibitor, zanamivir, subsequently marketed by GlaxoSmithKline as Relenza. Biota research breakthroughs include a series of candidate drugs aimed at treatment of respiratory syncytial virus (RSV) disease and Hepatitis C (HCV) virus infections. Biota has clinical trials underway with its lead compound for human rhinovirus (HRV) infection in patients with compromised respiration or immune systems.
In addition, Biota and Daiichi Sankyo co-own a range of second generation influenza anti-virals, of which the lead product lnavir®, is approved for marketing in Japan.
Relenza™ is a registered trademark of the GlaxoSmithKline group of companies.
Latest Media Releases
Latest News
Market Reports /
by -
11 years ago
16 May 2012 - ASX slumps 2.4%. BHP Billiton Limited (ASX:BHP) chief executive Marius Kloppers says most miners will face lower cash flows because of higher costs, lower commodity p…
Company News /
by -
12 years ago
23 Apr 2012 - Biota Holdings Limited (ASX:BTA) has inked a deal with US company Nabi Biopharmaceuticals.
Market Reports /
by -
12 years ago
27 Jun 2011 - Aus shares start week 1% down. Engineering company UGL Ltd (ASX:UGL) secures $400 million in new resource contracts from companies such as BHP Billiton Ltd (ASX:BHP),…
Market Reports /
by -
13 years ago
01 Apr 2011 - Energy stocks drive local gains. Gunns Ltd (ASX:GNS) will suspend its Tasmanian Triabunna woodchip operations because of the impact of the Japanese earthquake and str…
Company News /
by -
13 years ago
01 Apr 2011 - Biota Holdings Ltd (ASX:BTA) is awarded a $231 million contract from the US Department of Health and Human Services to develop influenza antiviral Laninamivir.
Market Reports /
by -
13 years ago
16 Feb 2011 - Aus shares flat as BHP drags. Shares in Biota Holdings Ltd (ASX:BTA) slump over 15 per cent after the company posts a half year loss of $15.95 million.
Market Reports /
by -
13 years ago
04 Feb 2011 - Shares in positive territory. Peter Crane, a member of the Crane Group Ltd’s (Public, ASX:CRG) founding family has taken to the internet to persuade shareholders to r…
Market Reports /
by -
13 years ago
10 Jan 2011 - Aus shares lower at midday. Drug developer Biota Holdings Ltd (ASX:BTA) has told the Australian Securities Exchange that it has no information to explain the recent j…
Market Reports /
by -
13 years ago
13 Sep 2010 - Aussie shares are higher at midday. Shares in Biota Holdings Ltd (ASX:BTA) rise after Biota announces its Japanese partner can now sell the Inavir influenza drug.
Stock Watch /
by -
13 years ago
Investment advisor James Gerrish takes a technical look at Dow Jones, FTSE 100, S&P ASX200, Financial Sector, RIO, GNS, BTA, ORG, TLS, CBA, BHP, QBE, MAP, Buy Hold Sell Recommendat…
Market Reports /
by -
14 years ago
The local share market is weaker at midday. Skilled Group Ltd's (ASX:SKE) CEO has resigned as the company downgrades its earnings outlook for the year.
Stock Watch /
by -
14 years ago
Trading manager James Gerrish takes a technical look at the S&P500, China's SSE Composite, CTX, RIO, DJS, BTA, AIO, MND, BOW, ESG, SUN, WPL, BKN, EQN, CEY, MCC, and FMG.
Market Reports /
by -
14 years ago
Aussie shares close lower. AED Oil Ltd (ASX:AED) acquires stakes in Nations Petroleum’s oil and gas contract areas in South East Asia.
